Aerpio Pharmaceuticals
Pharmaceutical ManufacturingOhio, United States11-50 Employees
Aerpio Pharmaceuticals is a pharmaceuticals company based out of 9987 Carver Road Suite 420, Cincinnati, Ohio, United States.
Recent Mergers Aerpio Pharmaceuticals has recently been involved in mergers with companies such as Aadibio and EyePoint Pharmaceuticals, indicating potential collaboration opportunities or new customer bases for sales expansion.
Financial Growth With recent funding of $155 million and revenue in the $0 - 10 million range, Aerpio Pharmaceuticals has the financial backing to invest in new technologies, expand product lines, and potentially increase sales efforts.
Strategic Partnerships The partnership with Gossamer Bio for the development of GB004 shows a commitment to collaboration and innovation, presenting opportunities for joint marketing efforts or cross-selling strategies to boost sales.
Clinical Trials Development Aerpio Pharmaceuticals' involvement in clinical trials for treatments like PAOG and AKB-9778 offers a platform to engage with healthcare providers, researchers, and patients, potentially leading to product adoption and increased sales.
Key Personnel Shift Dr. Pakola's transition from Chief Medical Officer at Aerpio Pharmaceuticals to REGENXBIO could serve as a connection point for sales outreach, leveraging existing networks and relationships for business development opportunities.
Aerpio Pharmaceuticals uses 8 technology products and services including W3 Total Cache, Segment, MySQL, and more. Explore Aerpio Pharmaceuticals's tech stack below.
Aerpio Pharmaceuticals Email Formats | Percentage |
FLast@aerpio.com | 43% |
Last@aerpio.com | 9% |
First@aerpio.com | 5% |
FLast@aerpio.com | 43% |
Pharmaceutical ManufacturingOhio, United States11-50 Employees
Aerpio Pharmaceuticals is a pharmaceuticals company based out of 9987 Carver Road Suite 420, Cincinnati, Ohio, United States.
Aerpio Pharmaceuticals has raised a total of $155M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2022 in the amount of $155Mas a investment in public equity (PIPE) financing round.
Aerpio Pharmaceuticals's revenue is in the range of $10M
Aerpio Pharmaceuticals has raised a total of $155M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2022 in the amount of $155Mas a investment in public equity (PIPE) financing round.
Aerpio Pharmaceuticals's revenue is in the range of $10M
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.